{"product_id":"lyme-disease-diagnostics-market-size-share-and-analysis-by-diagnostic-technology-serological-test-elisa-western-blot-lymphocytic-transformation-test-urine-antigen-testing-immunofluorescent-staining-nucleic-acid-test-and-others-by-sample-bloo","title":"Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Bloo","description":"\u003cp\u003eLyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public\/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032\u003cbr\u003e\nLyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public\/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032\u003c\/p\u003e\n\n\u003cp\u003ePRODUCT OVERVIEW:\u003c\/p\u003e\n\n\u003cp\u003eLyme disease is occurred due to a bacterial infection by borrelia species. This is spread through the bite of infected ticks in humans. The symptoms of Lyme disease in infected patients are fever, skin rashes, depression \u0026amp; fatigue. Early detection of the disease may be treated with antibiotics. By prolonging the disease without treating it, results in heart, joint and CNS disorders and might become fatal. The diagnostics intended to trat the lyme disease are called Lyme disease diagnostics.\u003c\/p\u003e\n\n\u003cp\u003eMARKET HIGHLIGHTS\u003c\/p\u003e\n\n\u003cp\u003eGlobal Lyme Disease Diagnostics Market is expected to project a CAGR of 6.8% during the forecast period, 2022-2032\u003c\/p\u003e\n\n\u003cp\u003eGlobal Lyme Disease Diagnostics Market is expected to reach USD 3.7 billion, growing at a CAGR of 6.8% during forecast period. Increasing focus of governments towards well establishment of healthcare facilities, growing prevalence of Lyme disease and the emergence of new Lyme disease diagnostic tests are expected to drive the growth of the Global Lyme Disease Diagnostics market. Rising enthusiasm of key players towards Research \u0026amp; Development of Lyme disease diagnosis is expected to drive the growth of the market.\u003c\/p\u003e\n\n\u003cp\u003eGLOBAL LYME DISEASE DIAGNOSTICS MARKET SEGMENTATION:\u003c\/p\u003e\n\n\u003cp\u003eSerological Test Segment is expected to grow with high CAGR during the forecast period\u003c\/p\u003e\n\n\u003cp\u003eGlobal Lyme Disease Diagnostics Market is classified based on the Diagnostic Technology into Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and Others. Serological test segment is expected to dominate the market in the forecast period owing to the preference of this test to measures the antibodies in the later phase of illness after nucleic acid test and PCR test which are advantageous in assessing Lyme disease.\u003c\/p\u003e\n\n\u003cp\u003eHospital Segment is expected to grow with high CAGR during the forecast period\u003c\/p\u003e\n\n\u003cp\u003eGlobal Lyme Disease Diagnostics Market is classified based on the End User into Hospitals, Public\/Private Laboratories, and Physicians Office. Hospital segment is expected to dominate the Lyme disease diagnostic market in the forecast period owing to the growing hospitals count with skilled professionals, availability of commercial diagnostic kits to identify Lyme disease easily and well-structured healthcare infrastructure which is expected to boost the market growth.\u003c\/p\u003e \n\n\u003cp\u003eMARKET DYNAMICS:\u003c\/p\u003e \n\n\u003cp\u003eGrowth Drivers\u003c\/p\u003e\n\n\u003cp\u003eIncreasing Patient Population is Expected to Boost the Growth of the Market\u003c\/p\u003e\n\n\u003cp\u003eIntroduction of New Initiatives by the Government is Expected to Boost the Growth of the Market\u003c\/p\u003e\n\n\u003cp\u003eRestraint\u003c\/p\u003e\n\n\u003cp\u003eLack of Disease Awareness May Hamper the Market Growth\u003c\/p\u003e\n\n\u003cp\u003eGLOBAL LYME DISEASE DIAGNOSTICS MARKET\u003c\/p\u003e\n\n\u003cp\u003eKey Players Covered: Bio-Rad Laboratories, Inc. Abbott Thermo Fisher Scientific, Inc. Oxford Immunotec Global PLC T2 Biosystems, Inc. Quidel Corporation Hoffmann-La Roche Ltd Graphene Frontiers Diasorin S.p.A Trinity Biotech Quest Diagnostics Other Prominent Player REGIONAL ANALYSIS\u003c\/p\u003e\n\n\u003cp\u003eGlobal Lyme Disease Diagnostics Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the Lyme disease diagnostics market in 2021 and is expected to dominate the same over the forecast period owing to the increasing government initiatives for diagnosing and treating of several diseases. The focus to develop new strategies in order to prevent Lyme disease has increased aiming to reduce occurrence of disease in population. The increment in pervasiveness of common tick disease, resulted in creating demand for disease treatment, thereby resulting in driving the growth of Lyme Disease Diagnostics Market. Reasons to Purchase this Report  Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors  Provision of market value (USD Billion) data for each segment and sub-segment  Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market  Analysis by geography highlighting the consumption of the product\/service in the region as well as indicating the factors that are affecting the market within each region  Competitive landscape which incorporates the market ranking of the major players, along with new service\/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled  Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players  The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions  Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis  Provides insight into the market through Value Chain  Market dynamics scenario, along with growth opportunities of the market in the years to come  3-month post-sales analyst support.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 249 Pages \/ MCW16236559","offer_id":47652193075506,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/lyme-disease-diagnostics-market-size-share-and-analysis-by-diagnostic-technology-serological-test-elisa-western-blot-lymphocytic-transformation-test-urine-antigen-testing-immunofluorescent-staining-nucleic-acid-test-and-others-by-sample-bloo","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}